BioCentury
ARTICLE | Company News

Alectos, Merck in discovery deal for AD

August 11, 2010 11:39 PM UTC

Alectos Therapeutics Inc. (Burnaby, B.C.) partnered with Merck & Co. Inc. (NYSE:MRK) to discover and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) for Alzheimer's dise...